Variablea
|
Clinic A (n = 71)
|
Clinic B (n = 176)
|
Total (N = 247)
|
p-value
|
---|
Age (years), mean ± SD
|
48.4 ± 8.4
|
45.9 ± 8.7
|
46.7 ± 8.6
|
0.051
|
Sex, male
|
18 (25.4)
|
41 (23.3)
|
59 (23.9)
|
0.865
|
Comorbidity
|
DM only
|
0 (0)
|
4 (2.3)
|
4 (1.6)
| |
HTN only
|
63 (88.7)
|
158 (89.8)
|
221 (89.5)
| |
DM and HTN
|
8 (11.3)
|
14 (7.9)
|
22 (8.9)
|
0.326
|
Time with NCD (years)
|
0–5
|
43 (60.6)
|
124 (70.5)
|
167 (67.6)
| |
6–10
|
20 (28.2)
|
4 (2.3)
|
24 (9.7)
| |
> 10
|
3 (4.2)
|
3 (1.7)
|
6 (2.4)
|
< 0.001
|
Missing
|
5 (7.0)
|
45 (25.6)
|
50 (20.2)
| |
Time with HIV (years)
|
0–5
|
31 (43.7)
|
91 (51.7)
|
122 (49.4)
| |
6–10
|
28 (39.4)
|
49 (27.8)
|
77 (31.7)
| |
> 10
|
11 (15.5)
|
15 (8.5)
|
26 (10.5)
| |
Missing
|
1 (1.4)
|
21 (11.9)
|
22 (8.9)
|
0.113
|
Time on ART (years)
|
0–5
|
48 (67.6)
|
139 (78.9)
|
187 (75.7)
| |
6–10
|
22 (30.9)
|
36 (20.5)
|
58 (23.5)
| |
> 10
|
1 (1.1)
|
1 (0.6)
|
2 (0.8)
|
0.155
|
WHO stage at HIV diagnosis
|
0
|
14 (19.7)
|
60 (34.1)
|
74 (29.9)
| |
1
|
21 (29.6)
|
53 (30.1)
|
74 (29.9)
| |
2
|
28 (39.5)
|
43 (24.4)
|
71 (28.7)
| |
3
|
6 (8.5)
|
15 (8.5)
|
21 (8.5)
| |
4
|
2 (2.8)
|
5 (2.8)
|
7 (2.8)
|
0.103
|
CD4 count at HIV diagnosisb
|
< 350
|
40 (56.3)
|
89 (50.6)
|
129 (52.2)
| |
≥ 350
|
25 (35.2)
|
42 (23.9)
|
67 (27.1)
| |
Missing
|
6 (8.5)
|
45 (25.6)
|
51 (20.7)
|
0.374
|
Median CD4 count at HIV diagnosis (IQR)b
|
294 (121–419)
|
249 (150–393)
|
261.5 (146–403.5)
| |
HIV suppression rates
|
64 (90.1)
|
147 (83.5)
|
211 (85.4)
| |
Missing
|
7 (9.9)
|
28 (15.9)
|
35 (14.2)
|
0.627
|
- HTN Hypertension, DM Diabetes mellitus type 2, DMHTN dual diagnosis of HTN and Diabetes Mellitus type 2, NCD non-communicable disease which implies either DM or HTN or both in this case, SD standard deviation of the mean
- aCharacteristics are described as n (%) where n is number of participants with the characteristic and % is percentage of the study population with the given characteristic
- bCells/µL
- Bold p values indicated statitistical significance